000			00629nam a2200193Ia 4500
999			_c3066 _d3066
005			20190503111145.0
008			180803s9999 xx 000 0 und d
020			_a978-1-118-14889-1
040			_aAIKTC-KRRC _cAIKTC-KRRC
041			_aENG
082			_a615.19 _bWAN/SIN _2DDC23
100			_aWang, Wei _94235
245		0	_aBiological drug products
250			_a1st
260			_aSussex _c2015
300			_a728 Pages _bPaperback
520			_aThis book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs –– a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues. Following this opening, the major classes of biologics are discussed: proteins and peptides, vaccines, oligonucleotides, and gene and regenerative medicines. A concluding section details administration and delivery routes and systems. The book incorporates both lessons learned and future directions to make for a valuable resource and reference for pharmaceutical scientists involved in the dynamic field of biologics.
650		0	_94639 _aPHARMACEUTICS
700			_aSingh, Manmohan _94236
856			_uhttps://ndl.iitkgp.ac.in/result?q={%22t%22:%22search%22,%22k%22:%22pharmaceutics%22,%22s%22:[%22DDC=\%22600%3A%3ATechnology\%22%22],%22b%22:{%22filters%22:[]}}
942			_cBK _2ddc